User:Kjmv21/sandbox
This is a user sandbox of Kjmv21. You can use it for testing or practicing edits. This is not the sandbox where you should draft your assigned article for a dashboard.wikiedu.org course. To find the right sandbox for your assignment, visit your Dashboard course page and follow the Sandbox Draft link for your assigned article in the My Articles section. |
== Week3 Tasks - Info For Nickel(II) cyclam perchlorate ==
(1.1, 1.3)Properties of Nickel (II) cyclam perchlorate
[edit]- Molecular formula: Ni(cyclam)(ClO4)2
- Molar Mass: 457.9 g/mol
- Melting Point: 140oC
- Boiling Point:
- Solubility In Water: somewhat soluble
(1.2,1.4)Nickel(II) Cyclam Perchlorate
(1.5)Citations
[edit]- Mechanism of Nitrogen Fixation by Nitrogenase: The Next Stage
- Mechanism of Mo-Dependent Nitrogenase
- The Nitrogenase Regulatory Enzyme Dinitrogenase Reductase ADP-Ribosyltransferase (DraT) Is Activated by Direct Interaction with the Signal Transduction Protein GlnB
Reference
[edit](1.6) Image
[edit](1.7) Table
[edit]opertyr
e |
|
---|---|
Molar Mass (g/mol) | 457.9 |
Melting point (oC) | 140 |
(1.8) Formula
[edit]
(1.9) Chem Box
[edit]Properties | |
---|---|
Ni(cyclam)(ClO4)2 | |
Molar mass | 457.9 g·mol |
Melting point | 140 °C (284 °F; 413 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
***REVISION Contributions for Ferrireductase article (first 250 words)
[edit]Ferric Fe(III) and Ferrous Fe(II) Solubility
[edit]Using the conversion of ascorbate (Vitamin C) to monodehydroascorbate is essential when the ferric Fe(III) ion is converted to ferrous Fe(II).The Fe(III) species is insoluble, hence becoming one of the most problematic metal species to introduce and dissolve into an organisms system.[1] Especially in eukaryotes such as humans, fungi, and bacteria, the upcycle of ascorbate is very important as well as the bioavailability of the ferrous (II) ion. There are three ways to increase the solubility of Iron (III) and overcome that challenge: chelation, reduction, and acidification.
Chelation
[edit]Chelation can increase the solubility of the iron (III) by coupling 'siderophore ligands' to the Iron species in its solid state to make it transform into an aqueous species. Especially in bacteria, and fungi, siderophores have a very strong binding affinity to Fe3+ and does not bind to other metal ions that may be present. The following is a general chemical equation to represent the process of chelation:
These iron complexes binds to a receptor on an iron transport that is unique to the siderophore used. The receptor dissociates once it nears the cell's membrane which creates an aqueous ferric Fe(III) ion that can either be used for uptake or reduced to Fe2+ where transporters specific to that ion can transport it instead.
Reduction
[edit]Reducing the ferrous (III) ion to ferrous (II) increases the bio availability which improves the rate and extent at which the aqueous soluble ferrous (II) iron will reach the system of the organism and will prevent the mineralization of the aqueous ferrous (III). The general for a following reduction in relation to an iron complex is as follows:
Once the iron complex nears the cell surface, the Iron (II) ion becomes susceptible to accept water ligands, thus hydrating the ion. This process usually occurs in aerobic environments where the Iron (II) ion is also favored. Once the complex is reduced, it must be then re-oxidized in proximity to the cell membrane because it contains binding sites typically only for Iron (III) ions that the protein will then undergo conformational changes to transition to the other side of the membrane.[2]
There are some transporters that allow the Iron (II) ions to be transported directly such as the Fet4, Dmt1, and the Irt1, however these transporters aren't exactly selective as they provide difficulty in binding to the Iron (II) ion so other ions bind as well such as Zn(II), Mn(II), and Cd(II).[3] Transportation like this mainly takes place in plants and in anaerobic environments where oxidation back to the Iron (III) species is impossible.[4]
`Contributions for Ferrireductase article (second 250 +400 words)
[edit]Importance
[edit]Ascorbate, commonly known as Vitamin C, is a nutrient that is necessary for the function of the human body. Ascorbate also protects the body from the formation of free radicals and through antioxidants, protects the body from their harmful effects. The ferrireductase that depends on ascorbate concentrations is called cytochrome b561 found in eukaryotes. Cytochrome b561, as mentioned above, is a diheme cytochrome, which is a protein that contains two coordinating iron complexes (a heme) with porphyrin ligands coupled to it. Cytochrome b561, along with two special amino acids, Lysine81 (oxidized), and Histidine106 (reduced), aid in catalyzing the electron transfer process and facilitate the conversion of ascorbate.[5] A diagram is provided to show the general mechanistic scheme of the conversion of ascorbate to monodehydroascorbate. One molecule of ascorbate binds to the designation site involving Lys81 (on the cytoplasmic side of an oxidized cytochrome b561) and donates an electron, ultimately producing monodehydroascorbate and a proton. Reversely, monohydroascorbate will bind to His106 (on the non-cytoplasmic side of reduced cytochrome b561) and accept both an electron and the proton previously generated, to regenerate another ascorbate to be used in the oxidized form again. In response to this mechanism, it facilitates the reduction of the ferric Fe (III) ion to the ferrous Fe(II) ion. A general reaction scheme of iron conversion in the plasma membrane is as follows:
The reduction of iron is crucial for the transport of iron through the cell membrane in human bodies since ferrous Fe (II) aqueous ions are more soluble and some transporters such as Ftr1 permease have high affinities for Fe2+.
References
[edit]- ^ Srai, S. K. S.; Bomford, Adrian; McArdle, Harry J. (2002-6). "Iron transport across cell membranes: molecular understanding of duodenal and placental iron uptake". Best Practice & Research. Clinical Haematology. 15 (2): 243–259. ISSN 1521-6926. PMID 12401306.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Nicklaus, M. C.; Wang, S.; Driscoll, J. S.; Milne, G. W. (1995-4). "Conformational changes of small molecules binding to proteins". Bioorganic & Medicinal Chemistry. 3 (4): 411–428. ISSN 0968-0896. PMID 8581425.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Waters, Brian; Eide, David (June 2002). "Combinatorial Control of Yeast FET4 Gene Expression by Iron, Zinc, and Oxygen*" (PDF). Journal of Biological Chemistry. 227: 33749–33757.
{{cite journal}}
: line feed character in|title=
at position 55 (help) - ^ Garrick, Michael D. (2011-2). "Human iron transporters". Genes & Nutrition. 6 (1): 45–54. doi:10.1007/s12263-010-0184-8. ISSN 1865-3499. PMC 3040799. PMID 21437029.
{{cite journal}}
: Check date values in:|date=
(help)CS1 maint: PMC format (link) - ^ Lu, Peilong; Ma, Dan; Yan, Chuangye; Gong, Xinqi; Du, Mingjian; Shi, Yigong (2014-02-04). "Structure and mechanism of a eukaryotic transmembrane ascorbate-dependent oxidoreductase". Proceedings of the National Academy of Sciences of the United States of America. 111 (5): 1813–1818. doi:10.1073/pnas.1323931111. ISSN 1091-6490. PMC 3918761. PMID 24449903.
{{cite journal}}
: CS1 maint: PMC format (link)